[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 29 of about 29
1. Cyriac S, Praveenkumar D, Majhi U, Sagar TG: Follicular dendritic cell sarcoma of the neck with an aggressive and fatal course. J Cancer Res Ther; 2010 Jan-Mar;6(1):114-6
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of the neck with an aggressive and fatal course.
  • Dendritic cell neoplasms are rare malignancies described with an increased frequency.
  • Surgery is the main modality though chemotherapy and radiation have also been tried.
  • We present here a case of a 69-year-old male diagnosed to have follicular dendritic cell sarcoma of the neck which had a rapid and fatal course inspite of chemotherapy and radiotherapy.
  • More studies are required to assess the biology of this rare tumor.
  • [MeSH-major] Dendritic Cell Sarcoma, Follicular / pathology. Head and Neck Neoplasms / pathology
  • [MeSH-minor] Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Fatal Outcome. Humans. Immunohistochemistry. Male. Radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20479564.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


2. Pisani F, Marino M, Sentinelli S, Petti MC: Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin. J Exp Clin Cancer Res; 2008;27:33
Hazardous Substances Data Bank. DOXORUBICIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin.
  • BACKGROUND: Follicular dendritic cell (FDC) sarcoma is a rare neoplasm arising in lymph nodes but also in extranodal sites from accessory cells of the immune system that are essential for the function of antigen presentation and germinal center reaction regulation.
  • FDC sarcoma has a significant recurrent and metastatic potential and for these reason it should be viewed as an intermediate grade malignancy.
  • METHODS: We report the case of a 49-year old woman patient who showed persistent, enlarged, hard, cervical lymph node.
  • Immunohistochemically, tumor cells were diffusely positive for follicular dendritic cell markers CD21, CD23 and negative for cytokeratin.The patient after complete excision of the lymph node underwent five courses of adjuvant chemotherapy with COP plus PEG-liposomal doxorubicin, considering the propensity of the tumor to metastasize.
  • CONCLUSION: These results suggest that this therapeutic modality may be useful in the management of FDC sarcoma.
  • [MeSH-major] Antibiotics, Antineoplastic / therapeutic use. Dendritic Cell Sarcoma, Follicular / therapy. Doxorubicin / therapeutic use. Head and Neck Neoplasms / therapy
  • [MeSH-minor] Chemotherapy, Adjuvant. Female. Humans. Lymph Nodes / pathology. Middle Aged. Receptors, Complement 3d / immunology. Receptors, IgE / immunology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 1986 Mar;122(3):562-72 [2420185.001]
  • [Cites] Tumori. 2003 May-Jun;89(3):237-49 [12908776.001]
  • [Cites] Semin Diagn Pathol. 1998 May;15(2):144-54 [9606805.001]
  • [Cites] Am J Hematol. 1998 Oct;59(2):161-7 [9766802.001]
  • [Cites] J Pak Med Assoc. 2006 Mar;56(3):137-9 [16696516.001]
  • [Cites] Virchows Arch. 2006 Aug;449(2):148-58 [16758173.001]
  • [Cites] Int J Clin Oncol. 2007 Feb;12(1):56-8 [17380443.001]
  • [Cites] J Clin Oncol. 1999 Jul;17(7):2290-2 [10561286.001]
  • [Cites] Histopathology. 2001 Jun;38(6):510-8 [11422494.001]
  • [Cites] Mod Pathol. 2002 Jan;15(1):50-8 [11796841.001]
  • [Cites] Histopathology. 2002 Jul;41(1):1-29 [12121233.001]
  • [Cites] Drugs. 2002;62(14):2089-126 [12269857.001]
  • [Cites] Auris Nasus Larynx. 2002 Oct;29(4):401-3 [12393051.001]
  • [Cites] Oral Oncol. 2003 Jun;39(4):415-9 [12676264.001]
  • [Cites] Clin Pharmacokinet. 2003;42(5):419-36 [12739982.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):294-313 [9010103.001]
  • (PMID = 18761751.001).
  • [ISSN] 1756-9966
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Receptors, Complement 3d; 0 / Receptors, IgE; 80168379AG / Doxorubicin
  • [Other-IDs] NLM/ PMC2556649
  •  go-up   go-down


3. Choi BS, Baek JH, Shin YM, Kim JH, Kim HW, Lee SJ, Cha HJ: Follicular dendritic cell sarcoma: a case report and review of the literature. Cancer Res Treat; 2010 Jun;42(2):121-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma: a case report and review of the literature.
  • Follicular dendritic cells (FDC) are non-lymphoid, non-phagocytic accessory cells of the immune system and these cells are essential for antigen presentation and regulation of the reactions in germinal centers.
  • Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that shows a low-to-intermediate malignant potential.
  • The patient improved after systemic chemotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Crit Rev Oncol Hematol. 2008 Jan;65(1):1-7 [17658269.001]
  • [Cites] Am J Hematol. 2007 Aug;82(8):725-8 [17373675.001]
  • [Cites] Am J Hematol. 1998 Oct;59(2):161-7 [9766802.001]
  • [Cites] Semin Diagn Pathol. 1998 May;15(2):155-60 [9606806.001]
  • [Cites] Histopathology. 2002 Jul;41(1):1-29 [12121233.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):944-55 [8712294.001]
  • [Cites] Am J Clin Pathol. 1995 May;103(5):543-60 [7741099.001]
  • [Cites] Am J Pathol. 1986 Mar;122(3):562-72 [2420185.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):294-313 [9010103.001]
  • (PMID = 20622968.001).
  • [ISSN] 2005-9256
  • [Journal-full-title] Cancer research and treatment : official journal of Korean Cancer Association
  • [ISO-abbreviation] Cancer Res Treat
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2901081
  • [Keywords] NOTNLM ; Dendritic cell sarcoma / Dendritic cells / Follicular / Lymph nodes
  •  go-up   go-down


Advertisement
4. Suhail Z, Musani MA, Afaq S, Zafar A, Ahmed Ashrafi SK: Follicular dendritic cell sarcoma of tonsil. J Coll Physicians Surg Pak; 2010 Jan;20(1):55-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of tonsil.
  • Follicular dendritic cell sarcoma is a very rare entity.
  • We present a new case of follicular dendritic cell sarcoma of the tonsil in a 52 years old woman with no evidence of neck node involvement.
  • The final diagnosis after histological review and immunohistochemical stains was follicular dendritic cell sarcoma.
  • One year follow-up after postoperative chemotherapy showed no evidence of local or regional recurrence.
  • Follicular dendritic cell sarcoma is a rare and underdiagnosed neoplasm.
  • It should be included in the differential diagnosis of any tonsillar mass in adults.
  • Follicular dendritic cell markers such as SR-100, CD21 and/or CD35 are essential for the diagnosis.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Sarcoma / pathology. Tonsillar Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Female. Humans. Immunohistochemistry. Middle Aged

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20141695.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


5. Ishihara S, Honda Y, Asato T, Nonaka M, Nakagawa S, Hirashima K, Hayashi N, Baba H, Iyama K: Interdigitating dendritic cell sarcoma of the ileum recurred in multiple lymph nodes and duodenum three years after operation without chemotherapy. Pathol Res Pract; 2010 Jul 15;206(7):514-8
MedlinePlus Health Information. consumer health - Intestinal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interdigitating dendritic cell sarcoma of the ileum recurred in multiple lymph nodes and duodenum three years after operation without chemotherapy.
  • Neoplasms derived from interdigitating dendritic cell are extremely rare.
  • Here we describe a case of a 47-year-old man with interdigitating dendritic cell sarcoma (IDCS) in the ileum.
  • The ileal tumor, measuring 2cm, was detected and resected with regional lymphadenectomy.
  • At that time, a pathologic diagnosis of malignant peripheral nerve sheath tumor was made.
  • The patient, who was not treated with chemotherapy, showed no signs of recurrence.
  • Oval to spindle-shaped atypical cells, which resembled ileal tumor cells, infiltrated into the lymph node and duodenum.
  • Based on the histologic and immunohistochemical analysis, the histopathologic diagnosis of IDCS was confirmed.
  • To our knowledge, five cases of IDCS arising in the intestinal tract have been reported to date, and only one case, treated with both surgery and chemotherapy, led to remission.
  • This is the first case that has a comparatively favorable prognosis without chemotherapy after surgery.
  • [MeSH-major] Dendritic Cell Sarcoma, Interdigitating / pathology. Duodenal Neoplasms / pathology. Ileal Neoplasms / pathology. Lymph Nodes / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Biomarkers, Tumor / analysis. Diagnostic Errors. Digestive System Surgical Procedures. Humans. Immunohistochemistry. Male. Middle Aged. Nerve Sheath Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier GmbH. All rights reserved.
  • (PMID = 20399026.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor
  •  go-up   go-down


6. Kim SY, Kang JH, Chun SH, Chang MH, Kim YS, Lee SN, Kim MS, Kang CS: Interdigitating dendritic cell sarcoma of the tonsil. Asia Pac J Clin Oncol; 2010 Sep;6(3):144-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interdigitating dendritic cell sarcoma of the tonsil.
  • Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare malignancy derived from antigen-presenting cells, with 55 cases reported thus far.
  • A standard treatment modality is still being debated.
  • Treatment with empiric antibiotics did not result in improvement of her symptoms.
  • The patient received four cycles of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy, and a clinically complete response was achieved followed by adjuvant radiation.
  • [MeSH-major] Dendritic Cell Sarcoma, Interdigitating / pathology. Tonsillar Neoplasms / pathology
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Female. Humans. Immunohistochemistry. Middle Aged. Prednisone / therapeutic use. Radiotherapy, Adjuvant. Tonsillectomy. Vincristine / therapeutic use

  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20887493.001).
  • [ISSN] 1743-7563
  • [Journal-full-title] Asia-Pacific journal of clinical oncology
  • [ISO-abbreviation] Asia Pac J Clin Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


7. Li L, Shi YH, Guo ZJ, Qiu T, Guo L, Yang HY, Zhang X, Zhao XM, Su Q: Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma. World J Gastroenterol; 2010 May 28;16(20):2504-19

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma.
  • AIM: To establish a model for prognosis assessment of extranodal follicular dendritic cell (FDC) sarcoma.
  • The tumor sizes ranged from 1.5 to 21 cm (mean, 7.4 cm).
  • Surgical resection was performed in 100 patients, followed by radiation and/or chemotherapy in 35 of them.
  • A size > or = 5 cm (P = 0.003), high-grade histology (P = 0.046) and a mitotic count > or = 5/10 HPF (P = 0.013) were associated with tumor recurrence.
  • CONCLUSION: Extranodal FDC tumors behave like soft tissue sarcomas.
  • [MeSH-major] Dendritic Cell Sarcoma, Follicular / diagnosis. Dendritic Cell Sarcoma, Follicular / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Disease-Free Survival. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / pathology. Prognosis. Retrospective Studies. Review Literature as Topic. Sarcoma / pathology. Treatment Outcome. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Protein p53 / metabolism. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2008 May;39(5):776-80 [18291441.001]
  • [Cites] Pathol Res Pract. 2009;205(2):149-53 [18774654.001]
  • [Cites] Jpn J Radiol. 2009 Jan;27(1):4-19 [19373526.001]
  • [Cites] Arch Pathol Lab Med. 2009 Apr;133(4):643-7 [19391666.001]
  • [Cites] Adv Anat Pathol. 2009 Jul;16(4):236-46 [19546611.001]
  • [Cites] Ann Diagn Pathol. 2009 Aug;13(4):257-62 [19608084.001]
  • [Cites] J Cardiothorac Surg. 2009;4:31 [19589162.001]
  • [Cites] Chin Med J (Engl). 2009 Jul 5;122(13):1595-7 [19719956.001]
  • [Cites] Histopathology. 2006 Oct;49(4):431-3 [16978210.001]
  • [Cites] J Clin Oncol. 1999 Jul;17(7):2290-2 [10561286.001]
  • [Cites] Mutat Res. 2000 Apr;462(2-3):365-80 [10767646.001]
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):882-8 [10843293.001]
  • [Cites] Cancer. 2000 Aug 1;89(3):664-72 [10931467.001]
  • [Cites] Arch Pathol Lab Med. 2000 Nov;124(11):1693-6 [11079028.001]
  • [Cites] Histopathology. 2001 Jan;38(1):25-9 [11135043.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):354-60 [11301353.001]
  • [Cites] Head Neck. 1999 May;21(3):273-5 [10208672.001]
  • [Cites] Am J Dermatopathol. 2005 Aug;27(4):327-32 [16121055.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):721-31 [11395549.001]
  • [Cites] Histopathology. 2001 Jun;38(6):510-8 [11422494.001]
  • [Cites] Surgery. 2001 Jul;130(1):109-11 [11436023.001]
  • [Cites] Hum Pathol. 2001 Jul;32(7):745-9 [11486174.001]
  • [Cites] Hum Pathol. 2001 Dec;32(12):1403-7 [11774177.001]
  • [Cites] Mod Pathol. 2002 Jan;15(1):50-8 [11796841.001]
  • [Cites] Am J Otolaryngol. 2002 Mar-Apr;23(2):93-8 [11893977.001]
  • [Cites] Histopathology. 2002 Jul;41(1):1-29 [12121233.001]
  • [Cites] Haematologica. 2003 Feb;88(2):ECR04 [12604428.001]
  • [Cites] Oral Oncol. 2003 Jun;39(4):415-9 [12676264.001]
  • [Cites] Pathol Int. 2004 Feb;54(2):124-31 [14720144.001]
  • [Cites] Hum Pathol. 2004 Feb;35(2):259-63 [14991546.001]
  • [Cites] Am J Surg Pathol. 2004 May;28(5):569-77 [15105643.001]
  • [Cites] Biotechniques. 2004 Jun;36(6):932-3 [15211740.001]
  • [Cites] Am J Surg Pathol. 2004 Aug;28(8):988-98 [15252304.001]
  • [Cites] Acta Gastroenterol Belg. 2004 Apr-Jun;67(2):223-7 [15285580.001]
  • [Cites] Am J Pathol. 1986 Mar;122(3):562-72 [2420185.001]
  • [Cites] Mol Cell Biol. 1986 May;6(5):1379-85 [2946935.001]
  • [Cites] Science. 1991 Jul 5;253(5015):49-53 [1905840.001]
  • [Cites] EMBO J. 1992 Oct;11(10):3513-20 [1396554.001]
  • [Cites] Oncogene. 1993 Feb;8(2):307-18 [8426740.001]
  • [Cites] Am J Surg Pathol. 1994 May;18(5):517-25 [8172326.001]
  • [Cites] Am J Clin Pathol. 1995 Jan;103(1):90-7 [7817952.001]
  • [Cites] Oncogene. 1995 Oct 5;11(7):1363-70 [7478558.001]
  • [Cites] Am J Surg Pathol. 1996 Jun;20(6):747-53 [8651355.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):944-55 [8712294.001]
  • [Cites] Am J Surg Pathol. 1996 Mar;20(3):313-24 [8772785.001]
  • [Cites] Histopathology. 1996 Jan;28(1):89-92 [8838129.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):294-313 [9010103.001]
  • [Cites] Am J Surg Pathol. 1997 Nov;21(11):1295-306 [9351567.001]
  • [Cites] Pathol Int. 1997 Oct;47(10):703-6 [9361105.001]
  • [Cites] Virchows Arch. 1998 Mar;432(3):293-8 [9532010.001]
  • [Cites] Br J Cancer. 1998 Jun;77(12):2230-8 [9649138.001]
  • [Cites] Clin Chem. 1998 Jul;44(7):1397-403 [9665415.001]
  • [Cites] Histopathology. 1998 Nov;33(5):465-70 [9839172.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Feb;87(2):209-14 [10052377.001]
  • [Cites] Head Neck. 1999 Mar;21(2):164-7 [10091986.001]
  • [Cites] Ann Diagn Pathol. 1999 Apr;3(2):92-8 [10196389.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2008 Jan;37(1):40-4 [18509984.001]
  • [Cites] Arch Pathol Lab Med. 2008 Oct;132(10):1683-7 [18834231.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2008 Jun;37(6):395-9 [19031719.001]
  • [Cites] Pediatr Blood Cancer. 2005 Oct 15;45(5):725-7 [15926163.001]
  • [Cites] Arch Pathol Lab Med. 2005 Nov;129(11):1480-3 [16253031.001]
  • [Cites] Haematologica. 2005 Nov;90 Suppl:ECR35 [16266926.001]
  • [Cites] J Clin Oncol. 2005 Dec 20;23(36):9425-6 [16361643.001]
  • [Cites] Am J Otolaryngol. 2006 May-Jun;27(3):207-10 [16647987.001]
  • [Cites] Jpn J Clin Oncol. 2006 Apr;36(4):249-53 [16533803.001]
  • [Cites] Pathol Res Pract. 2006;202(7):541-8 [16564140.001]
  • [Cites] Pathol Int. 2006 Aug;56(8):466-70 [16872443.001]
  • [Cites] Virchows Arch. 2006 Aug;449(2):148-58 [16758173.001]
  • [Cites] Am J Surg Pathol. 2002 May;26(5):662-9 [11979097.001]
  • [Cites] Arch Pathol Lab Med. 2006 Nov;130(11):1718-21 [17076538.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2006 Dec;263(12):1155-7 [16896752.001]
  • [Cites] Ann Diagn Pathol. 2006 Dec;10(6):357-62 [17126255.001]
  • [Cites] Clin Transl Oncol. 2006 Nov;8(11):837-8 [17134976.001]
  • [Cites] Hum Pathol. 2007 Apr;38(4):668-72 [17367608.001]
  • [Cites] AJR Am J Roentgenol. 2007 Jun;188(6):W554-6 [17515347.001]
  • [Cites] Am J Hematol. 2007 Aug;82(8):725-8 [17373675.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):346-52 [17721283.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2007 Jun;36(6):430-1 [17822636.001]
  • [Cites] Am J Clin Pathol. 2007 Nov;128(5):776-82 [17951199.001]
  • [Cites] Crit Rev Oncol Hematol. 2008 Jan;65(1):1-7 [17658269.001]
  • [Cites] Diagn Cytopathol. 2008 Jan;36(1):42-6 [18064686.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2007 Oct;36(10):660-5 [18194598.001]
  • (PMID = 20503450.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Tumor Suppressor Protein p53
  • [Other-IDs] NLM/ PMC2877180
  •  go-up   go-down


8. Tsunemine H, Akasaka H, Kusama T, Fujimoto K, Motoyama A, Aozasa K, Kodaka T: Hepatic follicular dendritic cell sarcoma favorably controlled by transcatheter arterial chemoembolization. Intern Med; 2010;49(24):2703-7
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic follicular dendritic cell sarcoma favorably controlled by transcatheter arterial chemoembolization.
  • A 78-year-old woman with multiple tumors in the liver and spleen was diagnosed with follicular dendritic cell (FDC) sarcoma based on the histological picture of splenectomized specimen and its expression of CD21 and CD 23.
  • As a paraneoplastic immune disorder, Coombs' test was positive although hemolysis was not obvious.
  • Since systemic chemotherapies were ineffective for residual liver tumors, transcatheter arterial chemoembolization (TACE) was performed with subsequent tumor reduction.
  • Currently, the patient is alive 27 months after the diagnosis with residual hepatic tumors favorably controlled by repeated TACE.
  • Our experience suggests that TACE is useful for the management of hepatic FDC sarcoma.
  • [MeSH-major] Chemoembolization, Therapeutic. Dendritic Cell Sarcoma, Follicular / therapy. Liver Neoplasms / therapy
  • [MeSH-minor] Aged. Catheterization, Peripheral / methods. Drug Therapy, Combination / methods. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21173546.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


9. Chera BS, Orlando C, Villaret DB, Mendenhall WM: Follicular dendritic cell sarcoma of the head and neck: case report and literature review. Laryngoscope; 2008 Sep;118(9):1607-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of the head and neck: case report and literature review.
  • OBJECTIVES/HYPOTHESIS: This article presents a case of a patient with follicular dendritic cell sarcoma (FDS), a rare neoplasm usually of the head and neck, and reviews the literature.
  • He was treated with neck dissection and postoperative irradiation and remains disease free 5.25 years after salvage treatment.
  • Twenty-eight percent of patients received adjuvant radiotherapy; 18% received adjuvant chemotherapy.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Head and Neck Neoplasms / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Biopsy, Fine-Needle. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Middle Aged. Positron-Emission Tomography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18596475.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Amiri-Kordestani L, Priebat D, Chia SH: Follicular dendritic cell sarcoma of the neck: case report and review of current diagnostic and management strategies. Ear Nose Throat J; 2010 Jul;89(7):E14-7
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of the neck: case report and review of current diagnostic and management strategies.
  • Follicular dendritic cell sarcoma (FDCS) is a rare malignant neoplasm that can clinically mimic a number of other tumors.
  • The prognosis tends to be worse for patients with large or high-grade tumors and/or an intra-abdominal tumor site.
  • Radiation therapy and/or chemotherapy may be considered for incompletely resected tumors and for tumors with poor prognostic features, but the exact role of adjuvant therapy is unknown.
  • We report a case of cervical FDCS in a 39-year-old black man, and we review the presentation and management of this disorder, with emphasis on the differential diagnosis.
  • [MeSH-major] Dendritic Cell Sarcoma, Follicular / radiography. Dendritic Cell Sarcoma, Follicular / surgery. Head and Neck Neoplasms / radiography. Head and Neck Neoplasms / surgery
  • [MeSH-minor] Adult. Biopsy. Diagnosis, Differential. Humans. Immunohistochemistry. Male. Risk Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628972.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Adam Z, Veselý K, Krejcí M, Pour L, Fakan F, Soumarová R, Neubauer J, Vanícek J, Cerný J, Kren L, Bolcák K, Smardová L, Hájek R, Mayer J: [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]. Vnitr Lek; 2009 Feb;55(2):147-57
Hazardous Substances Data Bank. ETOPOSIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
  • Interdigitating dendritic cell sarcoma is a rare neoplasm forming part of the group of malignancies derived from histocytic cell line.
  • The pathological process affected proximal tibial epiphysis and adjacent soft tissues.
  • Histological examination of a diagnostic excision specimen of the tumour in the tibia and the extirpated enlarged regional nodes in the left groin led to the diagnosis of interdigitating dendritic cell sarcoma.
  • The diagnosis was confirmed pathologically by another two centres in the Czech Republic and, due to the unusual nature of the diagnosis, also in Regensburg, Germany.
  • Treatment started with chemotherapy, applied to patients with aggressive lymphomas in the framework of clinical studies, i.e. a combination of MegaCHOP.
  • MegaCHOP therapy was therefore discontinued after the 4 cycles.
  • Subsequently, we referred the patient for a high-dose chemotherapy with autologous bone marrow transplantation, similarly to aggressive lymphomas.
  • The collection of blood producing stem cells from peripheral blood was successfully performed after ESHAP chemotherapy.
  • A verificatoin FDG-PET examination was performed before high-dose chemotherapy.
  • One month after ESHAP chemotherapy, BEAM high-dose chemotherapy with autologous transplantation of blood forming tissue was performed.
  • High-dose chemotherapy was followed up by radiotherapy targeted on the primary tumour in the crus (70 Gy).
  • The activity corresponded to the presence of viable tumour tissue in the primary nidus and new metastases in inguinal nodes, without proofs of further proliferation at the time.
  • Histological examination showed affection of the node by the same type of tumour, i.e. a continuing activity of the disease despite chemotherapy.
  • Due to suspected continuation of viable tumour in the crus judging by the intensity of accumulation of FDG-PET and the proof of a new affection of regional nodes, surgical treatment was preferred after the failure of chemotherapy.
  • This was followed by regional inguinal node region radiotherapy (56 Gy).
  • The last fourth PET-CT examination carried out 4 months after the radiation therapy of the inguinal region showed massive dissemination into the region ofileac and paraaortic nodes (lymphadenopathy up to 6 cm in diameter) with an activity of 5.9 to 6.73 SUV units.
  • Currently, we test the sensitiveness of the disease to 2-chlordeoxyadenosin and look for additional therapeutic options.
  • To our knowledge, the above description is the first documented case of interdigitating dendritic cell sarcoma located in the tibia and crus soft tissue.
  • We have not found any description of high-dose therapy supported by autologous transplantation of blood-forming tissue for this type of tumour in relevant literature.
  • In this case, we record chemoresistance to high-dose chemotherapy and certain radiosensitivty of the tumour at the same time.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bone Neoplasms / therapy. Dendritic Cell Sarcoma, Interdigitating / therapy. Drug Resistance, Neoplasm. Leg. Peripheral Blood Stem Cell Transplantation. Soft Tissue Neoplasms / therapy. Tibia
  • [MeSH-minor] Adult. Carmustine / administration & dosage. Cytarabine / administration & dosage. Etoposide / administration & dosage. Humans. Male. Melphalan / administration & dosage. Positron-Emission Tomography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CYTARABINE .
  • Hazardous Substances Data Bank. MELPHALAN .
  • Hazardous Substances Data Bank. Carmustine .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19348397.001).
  • [ISSN] 0042-773X
  • [Journal-full-title] Vnitr̆ní lékar̆ství
  • [ISO-abbreviation] Vnitr Lek
  • [Language] cze
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Czech Republic
  • [Chemical-registry-number] 04079A1RDZ / Cytarabine; 6PLQ3CP4P3 / Etoposide; Q41OR9510P / Melphalan; U68WG3173Y / Carmustine; BEAM regimen
  • [Number-of-references] 69
  •  go-up   go-down


12. Ludwig A: [Extranodal follicular dendritic cell sarcoma of the tonsils]. HNO; 2006 Sep;54(9):701-4
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extranodal follicular dendritic cell sarcoma of the tonsils].
  • Follicular dendritic cell (FDC) sarcoma is a rare tumor deriving from dendritic cells of the lymphoid follicle.
  • Only a few cases of extranodal manifestation of FDC sarcoma of the head and neck have been reported.
  • We describe the case of a 47-year-old woman with a FDC sarcoma of the left tonsil that first manifested 11 years ago.
  • She has suffered three recurrences since this time, at continually reducing intervals.
  • The patient underwent local tumor excisions, and then received an adjuvant chemotherapy with doxorubicin and ifosfamide when she presented with the third recurrence.
  • The 11 year follow-up bears out a more aggressive behaviour of FDC sarcoma than first assumed.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Sarcoma / pathology. Tonsillar Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 2002 May-Jun;64(3):229-32 [12037393.001]
  • [Cites] Am J Hematol. 1998 Oct;59(2):161-7 [9766802.001]
  • [Cites] Ear Nose Throat J. 2003 Jul;82(7):507-9 [12955835.001]
  • [Cites] Oral Oncol. 2003 Jun;39(4):415-9 [12676264.001]
  • [Cites] Mod Pathol. 2002 Jan;15(1):50-8 [11796841.001]
  • [Cites] Am J Pathol. 1986 Mar;122(3):562-72 [2420185.001]
  • [Cites] Am J Surg Pathol. 1996 Aug;20(8):944-55 [8712294.001]
  • [Cites] Am J Otolaryngol. 2002 Mar-Apr;23(2):93-8 [11893977.001]
  • [Cites] Head Neck. 1999 May;21(3):273-5 [10208672.001]
  • [Cites] J Neurosurg. 2003 Dec;99(6):1089-90 [14705740.001]
  • [Cites] Am J Surg Pathol. 1994 Feb;18(2):148-57 [8291653.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):294-313 [9010103.001]
  • (PMID = 16389561.001).
  • [ISSN] 0017-6192
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


13. Nakashima T, Kuratomi Y, Shiratsuchi H, Yamamoto H, Yasumatsu R, Yamamoto T, Komiyama S: Follicular dendritic cell sarcoma of the neck; a case report and literature review. Auris Nasus Larynx; 2002 Oct;29(4):401-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma of the neck; a case report and literature review.
  • Follicular dendritic cell (FDC) sarcomas, also known as dendritic reticulum cell tumors, are uncommon neoplasms arising from antigen-presenting cells in B-lymphofollicles of nodal and extra-nodal sites.
  • We report a case of FDC sarcoma arising in the neck.
  • A 56-year-old female presented with a left neck tumor.
  • Microscopically, the tumor showed spindle-shaped stromal cells with large oval and polygonal nuclei.
  • Adjuvant chemotherapy of cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) was given.
  • Literature review provides the current information for the diagnosis and treatment of this unusual tumor.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / radiography. Sarcoma / pathology. Sarcoma / radiography
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12393051.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 9
  •  go-up   go-down


14. Aboujaoude R, Alvarez JR, Alvarez M, Al-Khan A: Follicular dendritic cell sarcoma in pregnancy: case report and review of the literature. Am J Perinatol; 2006 Nov;23(8):459-61
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma in pregnancy: case report and review of the literature.
  • Follicular dendritic cell (FDC) sarcoma is a rare tumor.
  • Most cases that have been described involve lymph nodes in young adults, but have not been reported in pregnancy.
  • We describe the case of a 20-year-old woman with a FDC sarcoma diagnosed during pregnancy that initially presented as a painful mass in the right axilla.
  • The patient underwent a tumor excision and chemotherapy.
  • During her postpartum course, she received radiation therapy and chemotherapy.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Pregnancy Complications, Neoplastic / diagnosis. Sarcoma / diagnosis

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17094047.001).
  • [ISSN] 0735-1631
  • [Journal-full-title] American journal of perinatology
  • [ISO-abbreviation] Am J Perinatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 17
  •  go-up   go-down


15. Li J, Duan MH, Han B, Zhang W, Zhou DB, Zhao YQ, Shen T: [Dendritic cell sarcoma: 4 cases report with literature review]. Zhonghua Xue Ye Xue Za Zhi; 2008 Apr;29(4):263-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Dendritic cell sarcoma: 4 cases report with literature review].
  • OBJECTIVE: To describe the clinical and pathological features, treatment and prognosis of dendritic cell sarcoma (DCS).
  • METHODS: A group of DCS was described, including two cases of follicular dendritic cell sarcoma (FDCS), one each of interdigitating dendritic cell sarcoma (IDCS) and langerhans cell sarcoma (LCS).
  • Pathological diagnosis of lymph node biopsy was FDCS with positive CD21 and CD35.
  • Both patients achieved complete remission (CR) after 6 cycles of chemotherapy (CHOP: cyclophosphamide, epirubicin, vindesine, and prednisolone).
  • The diagnosis of LCS was established after excisional biopsy was taken from inguinal lymph node.
  • Electron microscope examination confirmed the presence of Birbeck granule in tumor cells.
  • Four cycles of chemotherapy (including ECHOP, FND) were administered, but the disease progressed.
  • CONCLUSION: DCS is a group of very rare sarcoma, FDCS, IDCS and LCS have different characteristic clinical features, immunophenotype and prognosis.
  • [MeSH-major] Dendritic Cell Sarcoma, Interdigitating

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18843982.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 13
  •  go-up   go-down


16. Chan AC, Chan KW, Chan JK, Au WY, Ho WK, Ng WM: Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology; 2001 Jun;38(6):510-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies.
  • AIMS: Hyaline-vascular Castleman's disease (HVCD) and follicular dendritic cell (FDC) sarcoma occurring in the nasopharynx are both extremely rare.
  • Hyaline- vascular Castleman's disease with FDC overgrowth was diagnosed in a recurrence 8 years later, and a frank FDC sarcoma developed at the same site 11 years after initial presentation.
  • The patient remained disease-free 3 years after excision and adjuvant chemotherapy.
  • The FDC sarcoma comprised swirling fascicles of spindly cells with indistinct cell borders.
  • Over-expression of p53 protein was observed in the FDC sarcoma and an increased number of weakly p53-positive spindly cells could also be demonstrated in the HVCD specimen.
  • This finding suggested a possible role of p53 in the evolution from HVCD to FDC sarcoma.
  • Critical analysis of the literature shows that, among the 13 reported cases of FDC sarcoma associated with Castleman's disease, possible progression from the latter to the former is documented in only two cases.
  • CONCLUSIONS: The sequential changes observed in the current case provide further evidence to strengthen the role of HVCD as a possible precursor of FDC sarcoma.
  • [MeSH-major] Dendritic Cells / pathology. Giant Lymph Node Hyperplasia / pathology. Nasopharyngeal Neoplasms / pathology. Nasopharynx / pathology. Sarcoma / pathology
  • [MeSH-minor] Adult. Antigens, Neoplasm / analysis. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Biomarkers, Tumor / analysis. Biopsy. Cell Transformation, Neoplastic. Chemotherapy, Adjuvant. Cyclophosphamide / administration & dosage. Doxorubicin / administration & dosage. Humans. Immunoenzyme Techniques. Male. Prednisone / administration & dosage. Treatment Outcome. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Castleman's Disease.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11422494.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  • [Number-of-references] 28
  •  go-up   go-down


17. Olnes MJ, Nicol T, Duncan M, Bohlman M, Erlich R: Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy. Leuk Lymphoma; 2002 Apr;43(4):817-21
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy.
  • Interdigitating dendritic cell sarcoma (IDCS) is an aggressive neoplasm of which fewer than 25 cases have been reported in the world literature.
  • Patients with this malignancy have been treated with chemotherapy regimens used against non-Hodgkin's lymphomas.
  • Staging of the tumor with CT scan, PET scan, and bone marrow biopsy demonstrated inguinal and abdominal lymphadenopathies, a large mass encasing the small bowel, and extensive liver infiltration.
  • Morphologic and cytochemical analysis of biopsies from the abdominal mass and inguinal node were consistent with a diagnosis of IDCS, and immunohistochemical stains of the lymph node were positive for CLA, Kp-1, S-100, while negative for CD1a, CD3, CD20, CKER, and HMB45.
  • Treatment of this patient with ABVD chemotherapy resulted in rapid clinical improvement with a marked decrease in tumor burden after two cycles of ABVD, and a complete response after six cycles of therapy.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dendritic Cells / pathology. Sarcoma / drug therapy

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12153170.001).
  • [ISSN] 1042-8194
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 11056-06-7 / Bleomycin; 5V9KLZ54CY / Vinblastine; 7GR28W0FJI / Dacarbazine; 80168379AG / Doxorubicin; ABVD protocol
  •  go-up   go-down


18. Yin WH, Yu GY, Ma Y, Rao HL, Lin SX, Shao CK, Liang Q, Guo N, Chen GQ, Zhou W, Zhao T, Zhu MG: [Follicular dendritic cell sarcoma: a clinicopathologic analysis of ten cases]. Zhonghua Bing Li Xue Za Zhi; 2010 Aug;39(8):522-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Follicular dendritic cell sarcoma: a clinicopathologic analysis of ten cases].
  • OBJECTIVE: To study the clinicopathologic features of follicular dendritic cell sarcoma (FDCS) and its differential diagnosis.
  • Histologically, the tumor cells had whorled, storiform or diffuse growth patterns.
  • Multinucleated tumor giant cells and intranuclear pseudoinclusions were occasionally seen.
  • There was a sprinkling of small lymphocytes and neutrophils within the tumor as well as in the perivascular region.
  • Immunohistochemical study showed that the tumor cells were diffusely or focally positive for CD21, CD23, CD35 and D2-40, but negative for LCA, CD20, CD3, CD1a, HMB45 and CK.
  • The remaining 5 patients were alive and disease-free after surgical excision (+/- chemotherapy and radiotherapy).
  • CONCLUSIONS: FDCS is a rare low to intermediate-grade malignant tumor.
  • Appropriate application of FDC markers, such as CD21, CD35 and D2-40, would be helpful for arriving at a correct diagnosis.
  • Most cases are associated with good prognosis after surgical treatment, with or without chemotherapy and radiotherapy.
  • [MeSH-major] Dendritic Cell Sarcoma, Follicular / pathology. Lymph Nodes / pathology. Tonsillar Neoplasms / pathology
  • [MeSH-minor] Adult. Antibodies, Monoclonal, Murine-Derived / metabolism. Dendritic Cell Sarcoma, Interdigitating / pathology. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Lymph Node Excision. Male. Meningioma / pathology. Middle Aged. Nasopharyngeal Neoplasms / pathology. Paraneoplastic Syndromes / complications. Pemphigus / complications. Receptors, Complement 3b / metabolism. Receptors, Complement 3d / metabolism. Receptors, IgE / metabolism. Young Adult

  • Genetic Alliance. consumer health - TEN.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21055030.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Receptors, Complement 3b; 0 / Receptors, Complement 3d; 0 / Receptors, IgE; 0 / monoclonal antibody D2-40
  •  go-up   go-down


19. Wu Q, Liu C, Lei L, Yan X, Wang B, Liu X, Yv L, Lv Y: Interdigitating dendritic cell sarcoma involving bone marrow in a liver transplant recipient. Transplant Proc; 2010 Jun;42(5):1963-6
MedlinePlus Health Information. consumer health - Liver Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interdigitating dendritic cell sarcoma involving bone marrow in a liver transplant recipient.
  • Liver transplantation is an effective treatment for patients with many kinds of liver diseases.
  • However, an increased risk of de novo malignancy has been reported in liver transplant recipients; immunosuppressive drugs have generally been identified as the primary culprit.
  • Interdigitating dendritic cell sarcoma (IDCS) is an exceedingly rare neoplasm arising from antigen-presenting cells of the immune system.
  • In this study, we have reported a case of IDCS with bone marrow involvement occurring in a 61-year-old female liver transplant recipient at 2 years after the procedure.
  • Routine examination revealed an abnormal white blood cell count and elevated serum lactate dehydrogenase.
  • Computerized tomography of the chest, abdomen, and pelvis were negative.
  • To obtain a definite diagnosis, we performed an excisional lymph node biopsy and a bone marrow biopsy.
  • Microscopically, the tumor was composed of spindle cells with pale to eosinophilic cytoplasm, ill-defined cell borders, and large pleomorphic nuclei with prominent nucleoli.
  • Follicular dendritic cell, lymphoid, epithelial, myoepithelial, and melanoma markers were negative.
  • She responded to chemotherapy.
  • This case demonstrates the importance of cancer prevention and early detection for liver transplant recipients.
  • [MeSH-major] Bone Marrow / pathology. Carcinoma, Hepatocellular / surgery. Dendritic Cell Sarcoma, Interdigitating / complications. Liver Neoplasms / surgery. Liver Transplantation / methods
  • [MeSH-minor] Female. Hepatitis B / complications. Humans. Liver Cirrhosis / surgery. Liver Cirrhosis / virology. Lymph Nodes / pathology. Middle Aged. Treatment Outcome

  • Genetic Alliance. consumer health - Liver Transplant.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20620556.001).
  • [ISSN] 1873-2623
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Azim HA, Elsedewy E, Azim HA Jr: Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature. Onkologie; 2007 Jul;30(7):381-4
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature.
  • Follicular dendritic cell sarcoma is a rare, malignant, non-lymphoid cell-derived tumor that originates from B-lymphoid follicles of nodal and extranodal sites.
  • Surgery and radiotherapy were considered the mainstay of treatment for localized disease.
  • As for the metastatic setting, classic lymphoma and sarcoma regimens were previously tested with dismal responses.
  • PATIENT AND METHODS: In this report, we examined imatinib in combination with gemcitabine and cisplatin for treating a male patient with metastatic follicular dendritic sarcoma to the liver and lung.
  • RESULTS: The patient achieved complete pathological remission confirmed by positron emission tomography (PET) scan after 8 cycles.
  • An imatinibbased combination could serve as a good therapeutic option for such cases.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dendritic Cells, Follicular. Head and Neck Neoplasms / drug therapy. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Piperazines / therapeutic use. Pyrimidines / therapeutic use. Sarcoma / secondary
  • [MeSH-minor] Benzamides. Biomarkers, Tumor / analysis. Cisplatin / administration & dosage. Cisplatin / adverse effects. Deoxycytidine / administration & dosage. Deoxycytidine / adverse effects. Deoxycytidine / analogs & derivatives. Follow-Up Studies. Humans. Imatinib Mesylate. Lymphatic Metastasis / pathology. Male. Middle Aged. Positron-Emission Tomography. Proto-Oncogene Proteins c-kit / analysis. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17596748.001).
  • [ISSN] 0378-584X
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Benzamides; 0 / Biomarkers, Tumor; 0 / Piperazines; 0 / Pyrimidines; 0W860991D6 / Deoxycytidine; 8A1O1M485B / Imatinib Mesylate; B76N6SBZ8R / gemcitabine; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; Q20Q21Q62J / Cisplatin
  • [Number-of-references] 20
  •  go-up   go-down


21. Gironet N, De Muret A, Machet L, Diot P, Rivollier C, Dumont P, Lorette G, Vaillant L: [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck]. Ann Dermatol Venereol; 2005 Jan;132(1):41-4
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck].
  • [Transliterated title] Pemphigus paranéoplasique révélateur du développement d'un sarcome à cellules dendritiques à partir d'une tumeur de Castleman pulmonaire.
  • The search for intercellular anti-substance antibodies on rat spleen was positive, corresponding to anti-envoplakin IgG and leading to the diagnosis of paraneoplastic pemphigus.
  • The thoracic x-ray and scan revealed a hilum tumor, the histological examination of which confirmed the diagnosis of Castleman's disease concomitant to sarcomatous transformation.
  • Following surgical treatment, the respiratory failure worsened.
  • The patient improved with systemic corticosteroids at the dose of 2 mg/kg/d and chemotherapy was initiated.
  • The transformation of the Castleman tumor into a sarcoma may have unmasked intra-cellular antigens (plakins), initiating the specific immune reaction.
  • [MeSH-major] Giant Lymph Node Hyperplasia / complications. Paraneoplastic Syndromes / etiology. Pemphigus / etiology. Sarcoma / complications. Sarcoma / etiology
  • [MeSH-minor] Adrenal Cortex Hormones / therapeutic use. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cell Transformation, Neoplastic. Dendritic Cells. Diagnosis, Differential. Fatal Outcome. Humans. Male. Oral Ulcer / etiology. Oral Ulcer / pathology. Respiratory Insufficiency

  • Genetic Alliance. consumer health - Castleman's Disease.
  • Genetic Alliance. consumer health - Pemphigus.
  • MedlinePlus Health Information. consumer health - Pemphigus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15746607.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  •  go-up   go-down


22. Toyoda K, Taniguchi J, Kikawa K, Uike N, Haraoka S, Ooshima K, Kikuchi M, Kawanishi H: Follicular dendritic cell sarcoma: ultrastructural and immunohistochemical studies. Intern Med; 2000 Nov;39(11):950-5
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma: ultrastructural and immunohistochemical studies.
  • A rare case of follicular dendritic cell (FDC) sarcoma is reported.
  • Computerized tomography showed cervical, supraclavicular, retroperitoneal, and paraaortic lymphadenopathies.
  • But tumors that arose both in the cervical and the left interscapular regions during the chemotherapy were immunohistochemically confirmed to be of follicular dendritic cell origin.
  • The ultrastructural findings were consistent with those of FDC sarcoma.
  • FDC sarcoma is a rare nonlymphoid cell-derived malignant tumor originating from the lymphoid tissue.
  • The diagnosis of FDC sarcoma is most accurately established by immunohistochemical methods, using its specific markers.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Dendritic Cells, Follicular / ultrastructure. Sarcoma / pathology. Sarcoma / ultrastructure. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / ultrastructure

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11065250.001).
  • [ISSN] 0918-2918
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] JAPAN
  •  go-up   go-down


23. Soriano AO, Thompson MA, Admirand JH, Fayad LE, Rodriguez AM, Romaguera JE, Hagemeister FB, Pro B: Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol; 2007 Aug;82(8):725-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.
  • Follicular dendritic cell sarcomas (FDCS) are grouped with the histiocytic and dendritic cell neoplasms.
  • The natural history and response to different treatments have not been well established.
  • Information on initial treatment was available in 11 patients, which included surgery alone in one patient, surgery and radiation in two, surgery and chemotherapy in one, chemotherapy alone in three, chemotherapy and radiation in one, surgery followed by radiation and chemotherapy in three patients.
  • In eight patients the initial chemotherapy regimen was cyclophosphamide, doxorubicin, vincristine, and prednisone.
  • Follicular sarcoma is an aggressive neoplasm.
  • Although most of the patients initially responded to treatment, the majority of them (81%) relapsed.
  • A better understanding of the biology of FDCS could guide our efforts in the development of new treatment modalities for this rare disease.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Sarcoma / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17373675.001).
  • [ISSN] 0361-8609
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA16672
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Number-of-references] 18
  •  go-up   go-down


24. Jiang L, Admirand JH, Moran C, Ford RJ, Bueso-Ramos CE: Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. Ann Diagn Pathol; 2006 Dec;10(6):357-62
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.
  • We report a rare case of mediastinal follicular dendritic cell (FDC) sarcoma involving the bone marrow.
  • The patient, a 46-year-old woman, had a clinically aggressive tumor in the anterior mediastinum that was initially diagnosed as a diffuse B-cell lymphoma.
  • She received chemotherapy but showed no significant improvement.
  • The diagnosis of FDC sarcoma was made based on histological examination and immunohistochemical findings, including strong positive staining of tumor cells for CD21, CD23, clusterin, and epidermal growth factor receptor (EGFR) and negative staining for CD20, CD30, CD45, CD1a, S-100, vimentin, and keratin cocktail.
  • Histological examination and immunohistochemical studies of a previous biopsy of the mediastinal mass confirmed the diagnosis of mediastinal FDC sarcoma.
  • The patient was treated with an appropriate chemotherapy regimen; 1 month later, follow-up bone marrow biopsy revealed no tumor cells.
  • Although FDC sarcoma is considered a low-grade tumor, the tumor in the present case not only developed at an unusual location with bone metastasis but also involved bone marrow.
  • This case also highlights the utility of EGFR as an immunohistochemical marker of dendritic cell tumors that could be used as a diagnostic tool and guide for choosing appropriate chemotherapy regimens.
  • [MeSH-major] Bone Marrow / pathology. Dendritic Cells, Follicular / pathology. Mediastinal Neoplasms / pathology. Sarcoma / pathology
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / analysis. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Etoposide / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Immunoenzyme Techniques. Methotrexate / administration & dosage. Middle Aged. Taxoids / administration & dosage. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17126255.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Taxoids; 0W860991D6 / Deoxycytidine; 15H5577CQD / docetaxel; 6PLQ3CP4P3 / Etoposide; B76N6SBZ8R / gemcitabine; UM20QQM95Y / Ifosfamide; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


25. Yang GC, Wang J, Yee HT: Interwoven dendritic processes of follicular dendritic cell sarcoma demonstrated on ultrafast papanicolaou-stained smears: a case report. Acta Cytol; 2006 Sep-Oct;50(5):534-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interwoven dendritic processes of follicular dendritic cell sarcoma demonstrated on ultrafast papanicolaou-stained smears: a case report.
  • BACKGROUND: Follicular dendritic cell (FDC) tumor is a rare tumor derived from accessory cells in the lymphoid follicles.
  • FDC tumors are typically diagnosed on histology based on immunoreactivity to at least 1 of the FDC markers (CD21, CD23 or CD35) or based on the characteristic ultrastructural feature of long, interwoven, cytoplasmic, dendritic processes connected by desmosomes.
  • CASE: We observed novel cytologic features of FDC sarcoma in a liver fine needle aspirate of a 46-year-old man status post surgery and chemotherapy for FDC sarcoma, originating in the gastrointestinal tract with metastases to the liver, pancreas and spleen.
  • In the Diff-Quik- and Papanicolaou-stained smears, the tumor cells presented in syncytial fragments as well as single cells, as previously reported in the cytologic literature.
  • The tumor cells possessed multipolar cytoplasmic processes rather than unipolar ones, as previously reported.
  • CONCLUSION: The ultrastructural features of a web of interwoven, dendritic, cytoplasmic processes of FDC tumor was demonstrated for the first time on cytology.
  • Observation of this feature may allow the diagnosis to be made on cytology prior to histology, immunohistochemistry or electron microscopy.
  • [MeSH-major] Dendritic Cells, Follicular / pathology. Gastrointestinal Neoplasms / pathology. Liver Neoplasms / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Antigens, Surface / analysis. Antigens, Surface / immunology. Antigens, Surface / metabolism. Biomarkers, Tumor / analysis. Biomarkers, Tumor / immunology. Biomarkers, Tumor / metabolism. Biopsy, Needle. Cell Shape. Diagnosis, Differential. Humans. Liver / pathology. Lymph Nodes / pathology. Male. Middle Aged. Papanicolaou Test / methods. Papanicolaou Test / standards. Predictive Value of Tests

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17017440.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface; 0 / Biomarkers, Tumor
  •  go-up   go-down


26. Gao WJ, Zhang R, Qiu HX, Shen YM, Zhang XH, Xue SL, Han Y: [Interdigitating dendritic cell sarcoma-a case report with literature review]. Zhonghua Xue Ye Xue Za Zhi; 2005 Apr;26(4):232-4
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Interdigitating dendritic cell sarcoma-a case report with literature review].
  • OBJECTIVE: To report a case of interdigitating dendritic cell sarcoma (IDCS).
  • PATIENT MATERIAL: The patient was a 41-year-old man with a lymph node bulging in the left neck.
  • The diagnosis of IDCS was made by immunohistochemistry and electron microscopy.
  • Treatment of this patient with ABVD regimen (adriamycin, bleomycin, vinblastine, dacarbazine) resulted in obvious improvement, but did not control the tumor infiltration.
  • Immunohistochemistry and electron microscopy are crucial in distinguishing it from other histiocytic/dendritic cell neoplasms.
  • IDCS displays an aggressive behaviour, and the responses to chemotherapy are variable.
  • [MeSH-major] Dendritic Cell Sarcoma, Interdigitating / diagnosis. Dendritic Cell Sarcoma, Interdigitating / metabolism
  • [MeSH-minor] Adult. Antigens, CD / analysis. Antigens, Differentiation, Myelomonocytic / analysis. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bleomycin / administration & dosage. Dacarbazine / administration & dosage. Doxorubicin / administration & dosage. Humans. Immunohistochemistry. Male. S100 Proteins / analysis. Treatment Outcome. Vinblastine / administration & dosage

  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15949268.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human; 0 / S100 Proteins; 11056-06-7 / Bleomycin; 5V9KLZ54CY / Vinblastine; 7GR28W0FJI / Dacarbazine; 80168379AG / Doxorubicin
  • [Number-of-references] 13
  •  go-up   go-down


27. Adam Z, Pour L, Veselý K, Krejcí M, Fakan F, Hofstädter F, Büchler T, Hajek R, Mayer J: Interdigitating dendritic cell sarcoma of the leg. Onkologie; 2009 Jun;32(6):364-5
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interdigitating dendritic cell sarcoma of the leg.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Dendritic Cell Sarcoma, Interdigitating / drug therapy. Dendritic Cell Sarcoma, Interdigitating / pathology. Leg / pathology. Soft Tissue Neoplasms / drug therapy. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Cyclophosphamide / administration & dosage. Doxorubicin / administration & dosage. Humans. Male. Prednisone / administration & dosage. Treatment Outcome. Vincristine / administration & dosage

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19521127.001).
  • [ISSN] 1423-0240
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Case Reports; Letter; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


28. Khalid T, Folman R: Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma. J Clin Oncol; 2005 Dec 20;23(36):9425-6
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma.
  • [MeSH-major] Liver Neoplasms / drug therapy. Sarcoma / drug therapy
  • [MeSH-minor] Abdominal Pain / etiology. Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cyclophosphamide / administration & dosage. Dendritic Cells. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Doxorubicin / administration & dosage. Humans. Male. Prednisone / administration & dosage. Tomography, X-Ray Computed. Vinblastine / administration & dosage. Vinblastine / analogs & derivatives. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Follicular Dendritic Cell Tumor.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. VINORELBINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16361643.001).
  • [ISSN] 0732-183X
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 5J49Q6B70F / Vincristine; 5V9KLZ54CY / Vinblastine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; B76N6SBZ8R / gemcitabine; Q6C979R91Y / vinorelbine; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


29. Nayer H, Murphy KM, Hawkins AL, Long PP, Gillison M, Borowitz M, Griffin CA: Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leuk Lymphoma; 2006 Dec;47(12):2651-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma.
  • [MeSH-major] Chromosome Aberrations. Dendritic Cells / metabolism. Proto-Oncogene Proteins c-bcl-2 / genetics. Sarcoma / drug therapy. Sarcoma / genetics. Submandibular Gland Neoplasms / drug therapy. Submandibular Gland Neoplasms / genetics
  • [MeSH-minor] Adult. Antineoplastic Agents / therapeutic use. Cytogenetics / methods. Fatal Outcome. Humans. Immunohistochemistry. Karyotyping. Lymph Nodes / pathology. Male

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Leuk Lymphoma. 2006 Dec;47(12):2447-8 [17169790.001]
  • (PMID = 17169812.001).
  • [ISSN] 1042-8194
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Proto-Oncogene Proteins c-bcl-2
  •  go-up   go-down






Advertisement